Compare LENZ & RBKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LENZ | RBKB |
|---|---|---|
| Founded | 2019 | 1860 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.8M | 185.5M |
| IPO Year | 2021 | 2018 |
| Metric | LENZ | RBKB |
|---|---|---|
| Price | $5.90 | $17.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | ★ 701.8K | 42.1K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 215.00 |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $19,088,000.00 | $2,984,000.00 |
| Revenue This Year | $50.42 | N/A |
| Revenue Next Year | $197.16 | N/A |
| P/E Ratio | ★ N/A | $86.10 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.23 | $9.41 |
| 52 Week High | $50.19 | $17.99 |
| Indicator | LENZ | RBKB |
|---|---|---|
| Relative Strength Index (RSI) | 36.78 | 60.72 |
| Support Level | $5.23 | $15.18 |
| Resistance Level | $10.42 | $17.92 |
| Average True Range (ATR) | 0.42 | 0.41 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 35.43 | 58.39 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.